DRUG:AU:AU-BetaShares Global Healthcare Currency Hedged (AUD)

ETF | Others |

Last Closing

USD 8.27

Change

0.00 (0.00)%

Market Cap

USD 0.17B

Volume

0.06M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-17 )

Largest Industry Peers for Others

ETFs Containing DRUG:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.42% 33% F 52% F
Dividend Return 3.15% 61% D- 45% F
Total Return 7.57% 42% F 55% F
Trailing 12 Months  
Capital Gain 8.82% 34% F 53% F
Dividend Return 3.29% 58% F 40% F
Total Return 12.10% 42% F 56% F
Trailing 5 Years  
Capital Gain 30.85% 75% C 63% D
Dividend Return 11.54% 50% F 34% F
Total Return 42.40% 80% B- 64% D
Average Annual (5 Year Horizon)  
Capital Gain 7.04% 76% C+ 56% F
Dividend Return 8.59% 72% C 54% F
Total Return 1.55% 53% F 34% F
Risk Return Profile  
Volatility (Standard Deviation) 8.43% 64% D 93% A
Risk Adjusted Return 101.93% 95% A 98% N/A
Market Capitalization 0.17B 34% F 65% D

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.